Cargando…
Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis
BACKGROUND/AIMS: Empiric antibiotics are given in combination with biliary drainage for acute cholangitis but sometimes turn out to be insensitive to microorganisms in blood and bile. Clinical outcomes were compared according to sensitivity to microorganisms detected in blood and bile culture to eva...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667925/ https://www.ncbi.nlm.nih.gov/pubmed/32050314 http://dx.doi.org/10.5009/gnl19248 |
_version_ | 1783610404064198656 |
---|---|
author | Kawamura, Satoshi Karasawa, Yuki Toda, Nobuo Nakai, Yousuke Shibata, Chikako Kurokawa, Ken Arai, Junya Funato, Kazuyoshi Kurosaki, Shigeyuki Maeshima, Shuya Kondo, Mayuko Kojima, Kentaro Ohki, Takamasa Seki, Michiharu Koike, Kazuhiko Tagawa, Kazumi |
author_facet | Kawamura, Satoshi Karasawa, Yuki Toda, Nobuo Nakai, Yousuke Shibata, Chikako Kurokawa, Ken Arai, Junya Funato, Kazuyoshi Kurosaki, Shigeyuki Maeshima, Shuya Kondo, Mayuko Kojima, Kentaro Ohki, Takamasa Seki, Michiharu Koike, Kazuhiko Tagawa, Kazumi |
author_sort | Kawamura, Satoshi |
collection | PubMed |
description | BACKGROUND/AIMS: Empiric antibiotics are given in combination with biliary drainage for acute cholangitis but sometimes turn out to be insensitive to microorganisms in blood and bile. Clinical outcomes were compared according to sensitivity to microorganisms detected in blood and bile culture to evaluate the impact of sensitivity to empiric antibiotics in cholangitis. METHODS: Consecutive patients who underwent biliary drainage for acute cholangitis were retrospectively studied. Clinical outcomes such as 30-day mortality, length of hospital stay and high care unit stay, organ dysfunction and duration of fever were compared in three groups group A (sensitive to both blood and bile culture), group B (sensitive to blood culture alone) and group C (insensitive to both blood and bile culture). RESULTS: Eighty episodes of cholangitis were classified according to sensitivity results 42, 32 and six in groups A, B and C. Escherichia coli and Klebsiella were two major pathogens. There were no significant differences in 30-day mortality rate (7%, 0%, and 0%, p=0.244), length of hospital stay (28.5, 21.0, and 20.5 days, p=0.369), organ dysfunction rate (14%, 25%, and 17%, p=0.500), duration of fever (4.3, 3.2, and 3.5 days, p=0.921) and length of high care unit stay (1.4, 1.2, and 1.7 days, p=0.070) in groups A, B and C. Empiric antibiotics were changed in 11 episodes but clinical outcomes appeared to be non-inferior even in 31 episodes of cholangitis who were on inadequate antibiotics throughout the course. CONCLUSIONS: Sensitivity of empiric antibiotics was not associated with clinical outcomes in acute cholangitis. |
format | Online Article Text |
id | pubmed-7667925 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Editorial Office of Gut and Liver |
record_format | MEDLINE/PubMed |
spelling | pubmed-76679252020-11-18 Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis Kawamura, Satoshi Karasawa, Yuki Toda, Nobuo Nakai, Yousuke Shibata, Chikako Kurokawa, Ken Arai, Junya Funato, Kazuyoshi Kurosaki, Shigeyuki Maeshima, Shuya Kondo, Mayuko Kojima, Kentaro Ohki, Takamasa Seki, Michiharu Koike, Kazuhiko Tagawa, Kazumi Gut Liver Original Article BACKGROUND/AIMS: Empiric antibiotics are given in combination with biliary drainage for acute cholangitis but sometimes turn out to be insensitive to microorganisms in blood and bile. Clinical outcomes were compared according to sensitivity to microorganisms detected in blood and bile culture to evaluate the impact of sensitivity to empiric antibiotics in cholangitis. METHODS: Consecutive patients who underwent biliary drainage for acute cholangitis were retrospectively studied. Clinical outcomes such as 30-day mortality, length of hospital stay and high care unit stay, organ dysfunction and duration of fever were compared in three groups group A (sensitive to both blood and bile culture), group B (sensitive to blood culture alone) and group C (insensitive to both blood and bile culture). RESULTS: Eighty episodes of cholangitis were classified according to sensitivity results 42, 32 and six in groups A, B and C. Escherichia coli and Klebsiella were two major pathogens. There were no significant differences in 30-day mortality rate (7%, 0%, and 0%, p=0.244), length of hospital stay (28.5, 21.0, and 20.5 days, p=0.369), organ dysfunction rate (14%, 25%, and 17%, p=0.500), duration of fever (4.3, 3.2, and 3.5 days, p=0.921) and length of high care unit stay (1.4, 1.2, and 1.7 days, p=0.070) in groups A, B and C. Empiric antibiotics were changed in 11 episodes but clinical outcomes appeared to be non-inferior even in 31 episodes of cholangitis who were on inadequate antibiotics throughout the course. CONCLUSIONS: Sensitivity of empiric antibiotics was not associated with clinical outcomes in acute cholangitis. Editorial Office of Gut and Liver 2020-11-15 2020-02-14 /pmc/articles/PMC7667925/ /pubmed/32050314 http://dx.doi.org/10.5009/gnl19248 Text en Copyright © 2020 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kawamura, Satoshi Karasawa, Yuki Toda, Nobuo Nakai, Yousuke Shibata, Chikako Kurokawa, Ken Arai, Junya Funato, Kazuyoshi Kurosaki, Shigeyuki Maeshima, Shuya Kondo, Mayuko Kojima, Kentaro Ohki, Takamasa Seki, Michiharu Koike, Kazuhiko Tagawa, Kazumi Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis |
title | Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis |
title_full | Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis |
title_fullStr | Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis |
title_full_unstemmed | Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis |
title_short | Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis |
title_sort | impact of the sensitivity to empiric antibiotics on clinical outcomes after biliary drainage for acute cholangitis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667925/ https://www.ncbi.nlm.nih.gov/pubmed/32050314 http://dx.doi.org/10.5009/gnl19248 |
work_keys_str_mv | AT kawamurasatoshi impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT karasawayuki impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT todanobuo impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT nakaiyousuke impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT shibatachikako impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT kurokawaken impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT araijunya impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT funatokazuyoshi impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT kurosakishigeyuki impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT maeshimashuya impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT kondomayuko impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT kojimakentaro impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT ohkitakamasa impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT sekimichiharu impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT koikekazuhiko impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis AT tagawakazumi impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis |